Author

Xian Wang

University of PittsburghORCID 0000-0002-0652-6498Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xian Wang1 paper · Sun Yat-sen University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

Ling DingiD· 2 shared Shenyu Sun· 2 shared Shou‐Jiang GaoiD· 2 shared Yufei HuangiD· 2 shared Arjun PennathuriD· 1 shared Karla PaniaguaiD· 1 shared Luping CheniD· 1 shared Man-Tzu Wang· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ling DingORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologymBioPeer-reviewedJun 12, 2025

KSHV Reprograms Host RNA Splicing via FAM50A to Activate STAT3 and Drive Oncogenic Cellular Transformation

Shenyu Sun, Karla Paniagua, Ling Ding…·Shou‐Jiang Gao

This study identifies FAM50A-mediated splicing reprogramming by KSHV as a mechanism to activate STAT3 and drive oncogenic transformation in mesenchymal stem cells.

3 citations

ratbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 23, 2025

CASTOR1: A Novel Tumor Suppressor Linking mTORC1 and KRAS Pathways in Tumorigenesis and Resistance to KRAS-Targeted Therapies in Non-Small Cell Lung Cancer

Xian Wang, Ling Ding, Shenyu Sun…·Shou‐Jiang Gao

This study identifies CASTOR1 as a tumor suppressor in NSCLC that modulates mTORC1 and KRAS signaling, and shows that its loss promotes tumorigenesis and resistance to KRAS inhibitors.

2 citations

mouseexperimental assay

𝕏 PostBluesky